|
1
|
Misra S, Chaturvedi A, Misra NC and Sharma
ID: Carcinoma of the gallbladder. Lancet Oncol. 4:167–176. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hundal R and Shaffer EA: Gallbladder
cancer: Epidemiology and outcome. Clin Epidemiol. 6:99–109.
2014.PubMed/NCBI
|
|
3
|
Sharma A, Sharma KL, Gupta A, Yadav A and
Kumar A: Gallbladder cancer epidemiology, pathogenesis and
molecular genetics: Recent update. World J Gastroenterol.
23:3978–3998. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Andia ME, Hsing AW, Andreotti G and
Ferreccio C: Geographic variation of gallbladder cancer mortality
and risk factors in chile: A population-based ecologic study. Int J
Cancer. 123:1411–1416. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sheth S, Bedford A and Chopra S: Primary
gallbladder cancer: Recognition of risk factors and the role of
prophylactic cholecystectomy. Am J Gastroenterol. 95:1402–1410.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Levy AD, Murakata LA and Rohrmann CA Jr:
Gallbladder carcinoma: Radiologic-pathologic correlation.
Radiographics. 21:295–314. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cipolla-Neto J and Amaral FGD: Melatonin
as a hormone: New physiological and clinical insights. Endocr Rev.
39:990–1028. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bhattacharya S, Patel KK, Dehari D,
Agrawal AK and Singh S: Melatonin and its ubiquitous anticancer
effects. Mol Cell Biochem. 462:133–155. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Su SC, Hsieh MJ, Yang WE, Chung WH, Reiter
RJ and Yang SF: Cancer metastasis: Mechanisms of inhibition by
melatonin. J Pineal Res. 62:622017. View Article : Google Scholar
|
|
10
|
Wei JY, Li WM, Zhou LL, Lu QN and He W:
Melatonin induces apoptosis of colorectal cancer cells through
HDAC4 nuclear import mediated by CaMKII inactivation. J Pineal Res.
58:429–438. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mao L, Dauchy RT, Blask DE, Dauchy EM,
Slakey LM, Brimer S, Yuan L, Xiang S, Hauch A, Smith K, et al:
Melatonin suppression of aerobic glycolysis (Warburg effect),
survival signalling and metastasis in human leiomyosarcoma. J
Pineal Res. 60:167–177. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chao CC, Chen PC, Chiou PC, Hsu CJ, Liu
PI, Yang YC, Reiter RJ, Yang SF and Tang CH: Melatonin suppresses
lung cancer metastasis by inhibition of epithelial-mesenchymal
transition through targeting to twist. Clin Sci (Lond).
133:709–722. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin YW, Lee LM, Lee WJ, Chu CY, Tan P,
Yang YC, Chen WY, Yang SF, Hsiao M and Chien MH: Melatonin inhibits
MMP-9 transactivation and renal cell carcinoma metastasis by
suppressing Akt-MAPKs pathway and NF-κB DNA-binding activity. J
Pineal Res. 60:277–290. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mao L, Summers W, Xiang S, Yuan L, Dauchy
RT, Reynolds A, Wren-Dail MA, Pointer D, Frasch T, Blask DE, et al:
Melatonin represses metastasis in Her2-postive human breast cancer
cells by suppressing RSK2 expression. Mol Cancer Res. 14:1159–1169.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bubner B and Baldwin IT: Use of real-time
PCR for determining copy number and zygosity in transgenic plants.
Plant Cell Rep. 23:263–271. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kumar R, Saneja A and Panda AK: An annexin
V-FITC-propidium iodide-based method for detecting apoptosis in a
non-small cell lung cancer cell line. Methods Mol Biol.
2279:213–223. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Faulstich H, Zobeley S, Rinnerthaler G and
Small JV: Fluorescent phallotoxins as probes for filamentous actin.
J Muscle Res Cell Motil. 9:370–383. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hu H, Dong Z, Wang X, Bai L, Lei Q, Yang
J, Li L, Li Q, Liu L, Zhang Y, et al: Dehydrocorydaline inhibits
cell proliferation, migration and invasion via suppressing
MEK1/2-ERK1/2 cascade in melanoma. Onco Targets Ther. 12:5163–5175.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi H, Bi H, Sun X, Dong H, Jiang Y, Mu H,
Liu G, Kong W, Gao R and Su J: Antitumor effects of tubeimoside-1
in NCI-H1299 cells are mediated by microRNA-126-5p-induced
inactivation of VEGF-A/VEGFR-2/ERK signaling pathway. Mol Med Rep.
17:4327–4336. 2018.PubMed/NCBI
|
|
20
|
Yu R, Tan TH and Kong AN: Butylated
hydroxyanisole and its metabolite tert-butylhydroquinone
differentially regulate mitogen-activated protein kinases. The role
of oxidative stress in the activation of mitogen-activated protein
kinases by phenolic antioxidants. J Biol Chem. 14:28962–28970.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Baiu I and Visser B: Gallbladder cancer.
JAMA. 320:12942018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang J, Hao H, Yao L, Zhang X, Zhao S,
Ling EA, Hao A and Li G: Melatonin suppresses migration and
invasion via inhibition of oxidative stress pathway in glioma
cells. J Pineal Res. 53:180–187. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Farriol M, Venereo Y, Orta X, Castellanos
JM and Segovia-Silvestre T: In vitro effects of melatonin on cell
proliferation in a colon adenocarcinoma line. J Appl Toxicol.
20:21–24. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Papazisis KT, Kouretas D, Geromichalos GD,
Sivridis E, Tsekreli OK, Dimitriadis KA and Kortsaris AH: Effects
of melatonin on proliferation of cancer cell lines. J Pineal Res.
25:211–218. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Petranka J, Baldwin W, Biermann J, Jayadev
S, Barrett JC and Murphy E: The oncostatic action of melatonin in
an ovarian carcinoma cell line. J Pineal Res. 26:129–136. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ordoñez R, Carbajo-Pescador S,
Prieto-Dominguez N, García-Palomo A, González-Gallego J and Mauriz
JL: Inhibition of matrix metalloproteinase-9 and nuclear factor
kappa B contribute to melatonin prevention of motility and
invasiveness in HepG2 liver cancer cells. J Pineal Res. 56:20–30.
2014. View Article : Google Scholar
|
|
27
|
Cutando A, López-Valverde A,
Arias-Santiago S, DE Vicente J and DE Diego RG: Role of melatonin
in cancer treatment. Anticancer Res. 32:2747–2753. 2012.PubMed/NCBI
|
|
28
|
Nordlund JJ and Lerner AB: The effects of
oral melatonin on skin color and on the release of pituitary
hormones. J Clin Endocrinol Metab. 45:768–774. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Malhotra S, Sawhney G and Pandhi P: The
therapeutic potential of melatonin: A review of the science.
MedGenMed. 3:462004.PubMed/NCBI
|
|
30
|
Yerneni LK and Jayaraman S:
Pharmacological action of high doses of melatonin on B16 murine
melanoma cells depends on cell number at time of exposure. Melanoma
Res. 13:113–117. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dubocovich ML, Delagrange P, Krause DN,
Sugden D, Cardinali DP and Olcese J: International union of basic
and clinical pharmacology. LXXV. Nomenclature, classification, and
pharmacology of G protein-coupled melatonin receptors. Pharmacol
Rev. 62:343–380. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Juszczak M, Roszczyk M, Kowalczyk E and
Stempniak B: The influence od melatonin receptors antagonists,
luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on
melatonin-dependent vasopressin and adrenocorticotropic hormone
(ACTH) release from the rat hypothalamo-hypophysial system. In
vitro and in vivo studies. J Physiol Pharmacol. 65:777–784.
2014.PubMed/NCBI
|
|
33
|
Baum B, Settleman J and Quinlan MP:
Transitions between epithelial and mesenchymal states in
development and disease. Semin Cell Dev Biol. 19:294–308. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen T, You Y, Jiang H and Wang ZZ:
Epithelial-mesenchymal transition (EMT): A biological process in
the development, stem cell differentiation, and tumorigenesis. J
Cell Physiol. 232:3261–3272. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zeisberg M and Neilson EG: Biomarkers for
epithelial-mesenchymal transitions. J Clin Invest. 119:1429–1437.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu S, Zhan M and Wang J:
Epithelial-to-mesenchymal transition in gallbladder cancer: From
clinical evidence to cellular regulatory networks. Cell Death
Discov. 3:170692017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Puhalla H, Herberger B, Soleiman A,
Filipits M, Laengle F, Gruenberger T and Wrba F: E-cadherin and
beta-catenin expression in normal, inflamed and cancerous
gallbladder tissue. Anticancer Res. 25:4249–4254. 2005.PubMed/NCBI
|
|
38
|
Kai K, Masuda M and Aishima S: Inverse
correlation between CD8+ inflammatory cells and
E-cadherin expression in gallbladder cancer: Tissue microarray and
imaging analysis. World J Clin Cases. 5:1–8. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Dong P, He XW, Gu J, Wu WG, Li ML, Yang
JH, Zhang L, Ding QC, Lu JH, Mu JS, et al: Vimentin significantly
promoted gallbladder carcinoma metastasis. Chin Med J (Engl).
124:4236–4244. 2011.PubMed/NCBI
|
|
40
|
Lee DG, Lee SH, Kim JS, Park J, Cho YL,
Kim KS, Jo DY, Song IC, Kim N, Yun HJ, et al: Loss of NDRG2
promotes epithelial-mesenchymal transition of gallbladder carcinoma
cells through MMP-19-mediated Slug expression. J Hepatol.
63:1429–1439. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Acloque H, Adams MS, Fishwick K,
Bronner-Fraser M and Nieto MA: Epithelial-mesenchymal transitions:
The importance of changing cell state in development and disease. J
Clin Invest. 119:1438–1449. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Buchegger K, Silva R, López J, Ili C,
Araya JC, Leal P, Brebi P, Riquelme I and Roa JC: The ERK/MAPK
pathway is overexpressed and activated in gallbladder cancer.
Pathol Res Pract. 213:476–482. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Lu KH, Su SC, Lin CW, Hsieh YH, Lin YC,
Chien MH, Reiter RJ and Yang SF: Melatonin attenuates osteosarcoma
cell invasion by suppression of C-C motif chemokine ligand 24
through inhibition of the c-Jun N-terminal kinase pathway. J Pineal
Res. 65:e125072018. View Article : Google Scholar : PubMed/NCBI
|
